Cargando…

Mitofusin-2 acts as biomarker for predicting poor prognosis in hepatitis B virus related hepatocellular carcinoma

OBJECTIVE: To investigate the expression of Mitofusin-2 (MFN2) in HCC tissues and its role in the development of HCC. METHODS: A total of 107 HCC specimens were collected for tissue microarray analysis and immunohistochemistry (IHC) analysis. The relationship between MFN2 expression and clinical fea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiumei, Liu, Youde, Sun, Jing, Gong, Wenjing, Sun, Ping, Kong, Xiangshuo, Yang, Miaomiao, Zhang, Weiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258311/ https://www.ncbi.nlm.nih.gov/pubmed/30498519 http://dx.doi.org/10.1186/s13027-018-0212-7

Ejemplares similares

Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma
por: Wang, Xiumei, et al.
Publicado: (2017)

Mitofusins: from mitochondria to fertility
por: Zhao, Shanjiang, et al.
Publicado: (2022)

Comparison of anti-HBV regimen with or without adefovir on hepatocellular carcinoma development of Chronic hepatitis B patients with compensated cirrhosis: a retrospective cohort study
por: Sun, Jing, et al.
Publicado: (2018)

Pro-diversity mitofusins
por: LeBrasseur, Nicole
Publicado: (2007)

The INs and OUTs of mitofusins
por: Giacomello, Marta, et al.
Publicado: (2018)

Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis
por: Sun, Quanquan, et al.
Publicado: (2020)

Clinical significance of mitofusin-2 and its signaling pathways in hepatocellular carcinoma
por: Wu, Yingsheng, et al.
Publicado: (2016)

Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma
por: Zhao, Gang, et al.
Publicado: (2013)

Prognostic value of postoperative change in liver stiffness in patients with HBV-related hepatocellular carcinoma
por: Liu, Youde, et al.
Publicado: (2020)

Bioinformatic analysis and in vitro validation of a five-microRNA signature as a prognostic biomarker of hepatocellular carcinoma
por: Li, Wang, et al.
Publicado: (2020)

ASPM May be Related to the Malignant Progression of Hepatitis B and is Associated With a Poor Prognosis of Hepatocellular Carcinoma
por: Tan, Siyou, et al.
Publicado: (2022)

Dengue Virus Impairs Mitochondrial Fusion by Cleaving Mitofusins
por: Yu, Chia-Yi, et al.
Publicado: (2015)

MicroRNA‐761 is upregulated in hepatocellular carcinoma and regulates tumorigenesis by targeting Mitofusin‐2
por: Zhou, Xiaohu, et al.
Publicado: (2016)

Galectin-9 expression predicts poor prognosis in hepatitis B virus-associated hepatocellular carcinoma
por: Jiao, Jianhua, et al.
Publicado: (2022)

Mitofusin 2: from functions to disease
por: Filadi, Riccardo, et al.
Publicado: (2018)

Homer2 and Homer3 Act as Novel Biomarkers in Diagnosis of hepatitis B virus-induced Hepatocellular Carcinoma
por: Luo, Ping, et al.
Publicado: (2021)

Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals
por: Fukumoto, Tsuyoshi, et al.
Publicado: (2022)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
por: Chen, Yibing, et al.
Publicado: (2018)

Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer
por: Zhu, Yanyun, et al.
Publicado: (2016)

Role of Mitofusin 2 in the Renal Stress Response
por: Gall, Jonathan M., et al.
Publicado: (2012)

Downregulation of Mitofusin 2 in Placenta Is Related to Preeclampsia
por: Yu, Jun, et al.
Publicado: (2016)

Mitofusin 2 keeps the respiratory chain on Q
por: Short, Ben
Publicado: (2015)

Mitochondrial fusion: Reaching the end of mitofusin’s tether
por: Formosa, Luke E., et al.
Publicado: (2016)

Mitofusin1 in oocyte is essential for female fertility
por: Hou, Xiaojing, et al.
Publicado: (2019)

Role of Mitofusins and Mitophagy in Life or Death Decisions
por: Joaquim, Mariana, et al.
Publicado: (2020)

Mitofusin 2 Dysfunction and Disease in Mice and Men
por: Dorn, Gerald W.
Publicado: (2020)

Back to The Fusion: Mitofusin-2 in Alzheimer’s Disease
por: Sita, Giulia, et al.
Publicado: (2020)

Modulating mitofusins to control mitochondrial function and signaling
por: Zacharioudakis, Emmanouil, et al.
Publicado: (2022)

SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma
por: Song, Guo-Qiang, et al.
Publicado: (2022)

MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin
por: Yun, Jina, et al.
Publicado: (2014)

Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Han, Qunying, et al.
Publicado: (2021)

Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
por: Jiang, Fenge, et al.
Publicado: (2022)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

The MFN1 and MFN2 mitofusins promote clustering between mitochondria and peroxisomes
por: Huo, Yinbo, et al.
Publicado: (2022)

Prognostic value of insulin-like growth factor 2 mRNA-binding protein 3 and vascular endothelial growth factor-A in patients with primary non-small-cell lung cancer
por: Liu, Jiannan, et al.
Publicado: (2019)

Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients
por: Liu, Can, et al.
Publicado: (2017)

Non-Cirrhotic Liver is Associated with Poor Prognosis of Hepatocellular Carcinoma: A Literature Review
por: Liu, Yan, et al.
Publicado: (2019)

CHKA mediates the poor prognosis of lung adenocarcinoma and acts as a prognostic indicator
por: Zhang, Li, et al.
Publicado: (2016)

IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Yang, Jie-Ru, et al.
Publicado: (2022)

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
por: Zhu, Zebin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2msfsb0vqfg6eu1j522nmtg4pk